GENE ONLINE|News &
Opinion
Blog

LATEST
Trials & Approvals HER2 Inhibitor
NERLYNX-XELODA Combo Bags FDA Approval for HER2 Positive Breast Cancer Treatment
2020-02-27
Technology CA-125
Endometriosis Precision Detection Company, V-CHECK Eyes Global Market
2020-02-26Partner
Trials & Approvals Bacterial Infections
EXBLIFEP Surpasses Phase III, Presents Novel Solution for Antibiotic Resistance Crisis in Treating Complicated UTI
2020-02-26
Company Presentations at BIO Asia-Taiwan 2020 Now Accepting Applications
2020-02-26
Trials & Approvals Cholesterol
FDA Approval of Cholesterol Lowering Drug, NEXLETOL, A Value-Add to Existing Treatments
2020-02-25
Technology CAG Repeat
Small molecule Fights Huntington Disease By Diminishing Vicious CAG Triplet Repeats
2020-02-24
Trials & Approvals
Relief for Patients as Baudax Bio’s Non-Opioid Analgesic Wins FDA Approval
2020-02-23
Trials & Approvals Depression
VistaGen’s Antidepressant Nasal Spray Succeeds Phase 2a Trial
2020-02-22
R&D Antibody-Drug Conjugate
Padcev Keytruda Combo Garners Breakthrough Therapy Designation for Urothelial Cancer
2020-02-20
R&D
SCLC Treatment Gets a Boost as PharmaMar’s Lurbinectedin Bags Priority Review Status
2020-02-19
FDA
Weekly Cover：Foundation Medicine and Chugai Partnership with National Cancer Center
2020-02-18
Trials & Approvals
VEGF Inhibitor, Beovu Gets EC Approval for Wet Age-Related Macular Degeneration Treatment
2020-02-18
Trials & Approvals Multiple Myeloma
GSK Wins EMA Approval to Market Multiple Myeloma Treatment
2020-02-16
Technology CRISPR
New ‘Minigene’ Insertion Approach Could Treat Rare Liver Disease in Mice
2020-02-15
Manufacturing Drug Withdrawal
Weight-Management Drug Belviq Withdraws from US Market
2020-02-14
1 … 191 192 193 194 195 … 218
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top